RXRX EPS Estimates
Recursion Pharmaceuticals, Inc.
$3.52
+$0.02(+0.57%)
40
Overall
60
Value
18
Tech
44
Quality
Market Cap
$2.19B
Volume
15.59M
52W Range
$2.77 - $5.24
Target Price
$6.99
RXRX EPS estimates: the consensus estimate for Recursion Pharmaceuticals, Inc.'s current fiscal year is -$0.93 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RXRX EPS Estimates
- EPS estimate, current quarter
- $-0.24
- EPS estimate, next quarter
- $-0.21
- EPS estimate, current year
- $-0.93
- EPS estimate, next year
- $-0.87
- EPS growth, 3-year
- -1.92%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.44 |
| 2024 | $-1.69 |
| 2023 | $-1.58 |
| 2022 | $-1.36 |
| 2021 | $-1.49 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RXRX | $3.52 | +0.6% | 15.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Recursion Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW